Atlas Trials

Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsis

Clinical trial NCT03940235 · UNKNOWN

Trial details

NCT number
NCT03940235
Sponsor
European Institute of Oncology
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Oligometastatic Prostate Cancer
Start date
2019-10-01
Primary completion
2023-12-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.